Figure 3From: Randomized study of the safety, pharmacokinetics, and bronchodilatory efficacy of a proprietary glycopyrronium metered-dose inhaler in study patients with chronic obstructive pulmonary disease Adjusted Mean (±standard error) change from baseline in FEV 1 parameters relative to placebo; provides a concise depiction of the mean change from baseline in peak FEV 1 , 12-hour FEV 1 , FEV 1 AUC 0–12 , 24 hour FEV 1 , FEV 1 AUC 0–24 , FEV 1 AUC 12–24 . Back to article page